Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

949 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trial.
Gold EB, Pierce JP, Natarajan L, Stefanick ML, Laughlin GA, Caan BJ, Flatt SW, Emond JA, Saquib N, Madlensky L, Kealey S, Wasserman L, Thomson CA, Rock CL, Parker BA, Karanja N, Jones V, Hajek RA, Pu M, Mortimer JE. Gold EB, et al. Among authors: jones v. J Clin Oncol. 2009 Jan 20;27(3):352-9. doi: 10.1200/JCO.2008.16.1067. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075284 Free PMC article. Clinical Trial.
A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study.
Pierce JP, Faerber S, Wright FA, Rock CL, Newman V, Flatt SW, Kealey S, Jones VE, Caan BJ, Gold EB, Haan M, Hollenbach KA, Jones L, Marshall JR, Ritenbaugh C, Stefanick ML, Thomson C, Wasserman L, Natarajan L, Thomas RG, Gilpin EA; Women's Healthy Eating and Living (WHEL) study group. Pierce JP, et al. Among authors: jones ve, jones l. Control Clin Trials. 2002 Dec;23(6):728-56. doi: 10.1016/s0197-2456(02)00241-6. Control Clin Trials. 2002. PMID: 12505249
Eating pathology and obesity in women at risk for breast cancer recurrence.
Rock CL, McEligot AJ, Flatt SW, Sobo EJ, Wilfley DE, Jones VE, Hollenbach KA, Marx RD. Rock CL, et al. Among authors: jones ve. Int J Eat Disord. 2000 Mar;27(2):172-9. doi: 10.1002/(sici)1098-108x(200003)27:2<172::aid-eat5>3.0.co;2-x. Int J Eat Disord. 2000. PMID: 10657890
The relationship between fatigue and light exposure during chemotherapy.
Liu L, Marler MR, Parker BA, Jones V, Johnson S, Cohen-Zion M, Fiorentino L, Sadler GR, Ancoli-Israel S. Liu L, et al. Among authors: jones v. Support Care Cancer. 2005 Dec;13(12):1010-7. doi: 10.1007/s00520-005-0824-5. Epub 2005 Apr 29. Support Care Cancer. 2005. PMID: 15864659 Free PMC article.
Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer.
Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, Dimsdale J, Cohen-Zion M, Fiorentino L. Ancoli-Israel S, et al. Among authors: jones v. Support Care Cancer. 2006 Mar;14(3):201-9. doi: 10.1007/s00520-005-0861-0. Epub 2005 Jul 12. Support Care Cancer. 2006. PMID: 16010529 Free PMC article.
Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
Mitchell MS, Abrams J, Thompson JA, Kashani-Sabet M, DeConti RC, Hwu WJ, Atkins MB, Whitman E, Ernstoff MS, Haluska FG, Jakowatz JG, Das Gupta TK, Richards JM, Samlowski WE, Costanzi JJ, Aronson FR, Deisseroth AB, Dudek AZ, Jones VE. Mitchell MS, et al. J Clin Oncol. 2007 May 20;25(15):2078-85. doi: 10.1200/JCO.2006.10.1709. J Clin Oncol. 2007. PMID: 17513813 Clinical Trial.
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer.
Schneider BP, Zhao F, Wang M, Stearns V, Martino S, Jones V, Perez EA, Saphner T, Wolff AC, Sledge GW Jr, Wood WC, Davidson NE, Sparano JA. Schneider BP, et al. Among authors: jones v. J Clin Oncol. 2012 Sep 1;30(25):3051-7. doi: 10.1200/JCO.2011.39.8446. Epub 2012 Jul 30. J Clin Oncol. 2012. PMID: 22851566 Free PMC article. Clinical Trial.
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS. Adams S, et al. J Clin Oncol. 2014 Sep 20;32(27):2959-66. doi: 10.1200/JCO.2013.55.0491. J Clin Oncol. 2014. PMID: 25071121 Free PMC article.
949 results